Supreme Court Health Reform Oral Arguments Leave Open Questions
This article was originally published in The Gray Sheet
Executive Summary
Device firms should not stop preparing for the 2.3% excise tax, scheduled to take effect next January. Still, justices during oral arguments March 26-28 did not take off the table the prospect of ruling the entire health care reform legislation void.
You may also be interested in...
House Adds Momentum, But Big Barriers To Device Tax Repeal Remain
Killing the 2.3% excise tax on U.S. device sales before it takes effect in January would be a major victory for the industry, but with opposition from the Senate and the White House, achieving repeal remains a steep climb at best.
House Adds Momentum, But Big Barriers To Device Tax Repeal Remain
Killing the 2.3% excise tax on U.S. device sales before it takes effect in January would be a major victory for the industry, but with opposition from the Senate and White House, achieving repeal remains a steep climb at best.
House Device Tax Repeal Effort May Raise Profile Of Issue In Election Season
Legislation to repeal the impending medical device excise tax will be sent to a vote on the House floor, raising the profile of the tax as a congressional election issue even as major impediments to repeal remain in the Senate. Meanwhile, the Supreme Court health care reform ruling looms.